potential second-line treatment for indolent lymphoma
Published 7 years ago • 251 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
4:01
first- and second-line treatment in dlbcl
-
1:17
changes in second-line lymphoma treatment
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
0:58
improving second-line treatments in dlbcl
-
3:37
chemotherapy-free management of indolent lymphoma
-
1:36
indolent lymphoma treatment in the us vs. europe
-
0:59
axi-cel as second-line therapy for r/r large b-cell lymphoma
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
3:46
battling relapsed diffuse large b-cell lymphoma (dlbcl) - sam's story
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
2:46
the success story of indolent disease treatment expanded to difficult-to-treat patient groups
-
2:14
access to therapy for indolent lymphomas in latin america
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
6:43
phase ii study of response-adapted ultra-low dose radiotherapy for b-cell lymphoma
-
2:35
next questions for mantle cell lymphoma
-
3:28
lymphoma: pre-treatment pet scans
-
1:00
efficacy of haploidentical sct for r/r classical hodgkin lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:11
the t-cell lymphoma project: prospective data collection changing the world
-
3:36
the real cost of hematological cancer care explained
-
1:34
pet-guided treatment: the new standard of care in hodgkin lymphoma?